FHTX vs MCD · rev $22.6M vs P/E 23, rev $25.92B
Foghorn Therapeutics Inc (FHTX) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
FHTX currently screens at market cap $237.8M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the FHTX and MCD stock pages for the full models.
Not investment advice.